Amantadine and levodopa in the treatment of Parkinson's disease

Authors:

Abstract
Twenty‐eight ambulatory patients with Parkinson's disease participated in successive double‐blind crossover trials of amantadine and levodopa. A comprehensive battery of tests was used to evaluate patient preference, neurologic symptoms and signs, quantitative neurologic performance, practical skills used in daily living, and neuropsychological performance. These permitted differential assessment of specific areas of function affected. Levodopa ameliorated functional disabilities, tremor, and loss of associated movements. It also improved grip strength, foot speed, foot coordination, gait, and several skilled activities more than did amantadine. The combination of levodopa and amantadine was more effective than levodopa alone in the management of total functional disability, tremor, and gait and in tests of grip strength, finger coordination, tracking, and tandem gait, as well as in the practiced skills of zipping, cutting, and opening a door. One neuropsychologic test‐picture completion‐was also better on the combination. The safety of the combination was affirmed and the relative efficacy quantitated.